MeadowBrook Investment Advisors LLC Buys 1,460 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

MeadowBrook Investment Advisors LLC increased its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 16.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 10,280 shares of the company’s stock after buying an additional 1,460 shares during the period. MeadowBrook Investment Advisors LLC’s holdings in Surgery Partners were worth $218,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. KBC Group NV grew its holdings in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after purchasing an additional 576 shares during the period. Point72 Asia Singapore Pte. Ltd. grew its holdings in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after purchasing an additional 3,379 shares during the period. Empowered Funds LLC bought a new position in Surgery Partners during the fourth quarter valued at $245,000. Creative Planning bought a new position in Surgery Partners during the third quarter valued at $258,000. Finally, Versor Investments LP bought a new position in Surgery Partners during the third quarter valued at $271,000.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Macquarie restated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. Bank of America started coverage on Surgery Partners in a research report on Monday, December 16th. They issued a “buy” rating and a $30.00 price objective on the stock. JPMorgan Chase & Co. lowered their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. Finally, Royal Bank of Canada lowered their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $36.56.

Insider Activity at Surgery Partners

In other news, CFO David T. Doherty sold 13,641 shares of the business’s stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the sale, the chief financial officer now directly owns 108,862 shares of the company’s stock, valued at $2,787,955.82. The trade was a 11.14 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jason Eric Evans sold 26,520 shares of the business’s stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.65, for a total transaction of $680,238.00. Following the sale, the chief executive officer now directly owns 560,698 shares in the company, valued at $14,381,903.70. This trade represents a 4.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 96,733 shares of company stock valued at $2,480,106 over the last ninety days. 2.30% of the stock is owned by company insiders.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY opened at $25.75 on Wednesday. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $35.29. The firm has a 50-day simple moving average of $21.88 and a two-hundred day simple moving average of $26.90.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.15 EPS. As a group, research analysts anticipate that Surgery Partners, Inc. will post 0.71 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.